サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1595072

幹細胞製造の世界市場

Stem Cell Manufacturing

出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.70円
幹細胞製造の世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

幹細胞製造の世界市場は2030年までに230億米ドルに達する見込み

2023年に135億米ドルと推定される幹細胞製造の世界市場は、2023年から2030年にかけてCAGR 7.9%で成長し、2030年には230億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである培地は、CAGR 7.7%を記録し、分析期間終了までに92億米ドルに達すると予測されます。消耗品セグメントの成長率は、分析期間中CAGR 8.0％と推定されます。

米国市場は36億米ドル、中国はCAGR 7.4％で成長すると予測

米国の幹細胞製造市場は2023年に36億米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 7.4%で推移し、2030年には予測市場規模36億米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.0％と6.6％と予測されています。欧州では、ドイツがCAGR約6.1%で成長すると予測されています。

世界の幹細胞製造市場- 主要動向と促進要因のまとめ

幹細胞製造は医療の進歩をどのように支えているのか？

幹細胞製造は、治療、研究、臨床応用のための幹細胞の大量生産に関与しています。幹細胞は様々な細胞に分化する能力を持つことで知られており、再生医療、疾患モデル、創薬、個別化医療において重要な役割を担っています。製造プロセスには、細胞の調達、分離、拡大、分化、品質管理が含まれ、治療や研究に使用する高純度で生存可能な幹細胞を確保します。再生医療が進化し続ける中、幹細胞製造は脊髄損傷、神経変性疾患、糖尿病、心血管疾患などの治療法の開発に不可欠なものとなっており、臨床試験と商業的治療の両方をサポートしています。

幹細胞製造市場の主要セグメントは？

主要製品カテゴリーには、幹細胞株、培養メデューム、消耗品、器具が含まれ、培養メデュームは幹細胞の生存性を維持し、生産中の拡張をサポートするという重要な役割を果たすため、最大の市場シェアを占めています。用途としては、研究開発、臨床試験、治療用などがあり、中でも臨床試験は、様々な慢性疾患や希少疾患に対応するための幹細胞治療の必要性から、重要なセグメントを占めています。エンドユーザーには、バイオ製薬企業、研究機関、病院、専門クリニックなどが含まれ、バイオ製薬企業は新しい幹細胞治療の開発と商業化のために大規模生産に投資しており、市場をリードしています。

幹細胞製造はどのように医療と研究に統合されているのでしょうか？

臨床の場では、幹細胞製造は血液疾患、免疫疾患、臓器障害などの疾患を対象とした再生治療に必要な細胞の量と質を提供し、より個別化された効果的な治療をサポートします。研究開発において、幹細胞は疾病メカニズムの研究、薬剤候補のスクリーニング、毒性評価に使用され、より迅速で正確な創薬プロセスを可能にします。臨床試験においては、一貫した幹細胞生産が規制基準の遵守と患者の安全性を確保する上で極めて重要であり、CAR-T細胞治療や組織工学のような先進的な治療法の開発を促進します。さらに、自動化、バイオプロセス、凍結保存の進歩により、幹細胞の生産効率、拡張性、流通性が向上しています。

幹細胞製造市場の成長を促進する要因は何か？

幹細胞製造市場の成長は、心血管疾患、神経疾患、自己免疫疾患など、さまざまな疾患のアンメット・メディカル・ニーズに対応する再生療法に対する需要の増加など、いくつかの要因によって牽引されています。細胞培養技術、バイオリアクター、自動化における進歩は、幹細胞生産におけるスケーラビリティ、一貫性、費用対効果を改善し、より広範な臨床および商業的応用を支援しています。個別化医療や標的治療への注目は、幹細胞によって個々の患者のプロファイルに基づいたオーダーメイド治療が可能になることから、需要をさらに押し上げています。加えて、バイオテクノロジー研究への投資の増加、政府による規制の後押し、研究機関とバイオ医薬品企業との協力関係の高まりが、多様な医療応用のための大規模な幹細胞製造を促し、市場の成長に寄与しています。

セグメント

製品（培養液、消耗品、器具、幹細胞株）;用途（調査ベース、細胞・組織バンキング、臨床ベース）

調査対象企業の例（注目の33社）

  • Anterogen
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Cellular Dynamics International
  • Holostem Terapie Avanzate
  • Lonza Group
  • Medipost
  • Merck Group
  • Miltenyi Biotec
  • Osiris Therapeutics
  • Pharmicell
  • Pluristem Therapeutics
  • Stemcell Technologies
  • Takara Bio Group
  • Thermo Fisher Scientific

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22861

Global Stem Cell Manufacturing Market to Reach US$23.0 Billion by 2030

The global market for Stem Cell Manufacturing estimated at US$13.5 Billion in the year 2023, is expected to reach US$23.0 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Culture Media, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 7.4% CAGR

The Stem Cell Manufacturing market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Stem Cell Manufacturing Market - Key Trends and Drivers Summarized

How Is Stem Cell Manufacturing Supporting Medical Advancements?

Stem cell manufacturing involves the large-scale production of stem cells for therapeutic, research, and clinical applications. Stem cells, known for their ability to develop into various cell types, play a critical role in regenerative medicine, disease modeling, drug discovery, and personalized medicine. The manufacturing process encompasses cell sourcing, isolation, expansion, differentiation, and quality control, ensuring high-purity, viable stem cells for use in treatments or studies. As regenerative medicine continues to evolve, stem cell manufacturing has become essential for developing therapies for conditions like spinal cord injuries, neurodegenerative diseases, diabetes, and cardiovascular disorders, supporting both clinical trials and commercial treatments.

What Are the Key Segments in the Stem Cell Manufacturing Market?

Key product categories include stem cell lines, culture media, consumables, and instruments, with culture media holding the largest market share due to its vital role in maintaining stem cell viability and supporting expansion during production. Applications cover research and development, clinical trials, and therapeutic use, with clinical trials representing a significant segment driven by the need for stem cell therapies to address various chronic and rare diseases. End-users include biopharmaceutical companies, research institutions, hospitals, and specialty clinics, with biopharmaceutical firms leading the market as they invest in large-scale production to develop and commercialize new stem cell-based therapies.

How Is Stem Cell Manufacturing Integrated Across Medicine and Research?

In clinical settings, stem cell manufacturing provides the necessary volume and quality of cells for regenerative therapies targeting conditions like blood disorders, immune diseases, and organ damage, supporting more personalized and effective treatments. In research and development, stem cells are used to study disease mechanisms, screen drug candidates, and evaluate toxicity, enabling faster and more accurate drug discovery processes. For clinical trials, consistent stem cell production is crucial to ensuring compliance with regulatory standards and patient safety, facilitating the development of advanced therapies like CAR-T cell treatments and tissue engineering. Additionally, advances in automation, bioprocessing, and cryopreservation have improved stem cell production efficiency, scalability, and distribution.

What Factors Are Driving the Growth in the Stem Cell Manufacturing Market?

The growth in the Stem Cell Manufacturing market is driven by several factors, including increasing demand for regenerative therapies that address unmet medical needs across various diseases, such as cardiovascular, neurological, and autoimmune disorders. Advancements in cell culture techniques, bioreactors, and automation have improved scalability, consistency, and cost-effectiveness in stem cell production, supporting broader clinical and commercial applications. The focus on personalized medicine and targeted treatments has further fueled demand, as stem cells enable customized therapies based on individual patient profiles. Additionally, rising investments in biotechnology research, supportive government regulations, and growing collaboration between research institutes and biopharma companies have contributed to market growth, encouraging large-scale stem cell manufacturing for diverse medical applications.

SCOPE OF STUDY:

The report analyzes the Stem Cell Manufacturing market in terms of US$ Million by the following Application; Product, and Geographic Regions/Countries:

Segments:

Product (Culture Media, Consumables, Instruments, Stem Cell Lines); Application (Research-based, Cell & Tissue Banking, Clinical-based)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Anterogen
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Cellular Dynamics International
  • Holostem Terapie Avanzate
  • Lonza Group
  • Medipost
  • Merck Group
  • Miltenyi Biotec
  • Osiris Therapeutics
  • Pharmicell
  • Pluristem Therapeutics
  • Stemcell Technologies
  • Takara Bio Group
  • Thermo Fisher Scientific

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Stem Cell Manufacturing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Autologous and Allogeneic Stem Cell Therapies Spurs Market Growth
    • Advancements in Bioprocessing Technologies Propel Manufacturing Capabilities
    • Expansion of Cell and Gene Therapy Expands Addressable Market
    • Growing Use of Stem Cells in Drug Development Strengthens Business Case
    • Rising Focus on Personalized Medicine Drives Adoption of Stem Cell Manufacturing
    • Increasing Use in Disease Modeling and Tissue Engineering Fuels Growth
    • Emergence of Automated Cell Culture Technologies Expands Opportunities
    • Rising Focus on Oncology and Cardiovascular Applications Spurs Adoption
    • Emergence of 3D Culture Technologies Strengthens Market Growth
    • Rising Need for Scalable Manufacturing Solutions Accelerates Demand
    • Increasing Use of Stem Cells in Regenerative Orthopedics Propels Manufacturing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Stem Cell Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Stem Cell Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Culture Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Stem Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Stem Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Stem Cell Lines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Research-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Research-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Research-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cell & Tissue Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cell & Tissue Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Cell & Tissue Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Clinical-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Stem Cell Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • JAPAN
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • CHINA
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • EUROPE
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Stem Cell Manufacturing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Stem Cell Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • FRANCE
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • GERMANY
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2014, 2024 & 2030

IV. COMPETITION